Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Tatlisumak Medical Consulting Oy
OY
Dissolved
Y-tunnus 3116687-1
F 231, 00350
Helsinki
Medical specialists activities
· NACE 8622
Est. 2020
1 employees
Share
Finland
/
Companies
/
Medical specialists activities
/
Tatlisumak Medical Consulting Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
EUR thousands
Item
2021
2022
2023
2024
2025
Revenue
24
108
127
148
149
Staff expenses
−12
−20
−45
−57
−64
EBITDA
4
60
49
54
47
Depreciation & amort.
—
—
−0
−0
−0
EBIT
4
60
49
54
47
Net financials
—
−0
−1
−1
−1
Profit before tax
4
60
49
53
46
Tax
−0
12
10
11
10
Net profit
4
47
39
42
36
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
2025
Total assets
6
64
96
123
152
Equity
4
51
85
120
147
Long-term debt
—
—
0
0
0
Short-term debt
2
13
11
3
5
Total debt
2
13
11
3
5
Financial ratios
5-year trend
EBITDA margin
31.5%
This company
15.8%
Market median
+99% vs market
2021
2025
Equity ratio
96.6%
This company
38.2%
Market median
+153% vs market
2021
2025
Return on equity
24.8%
This company
18.4%
Market median
+35% vs market
2021
2025
Net profit margin
24.5%
This company
8.1%
Market median
+202% vs market
2021
2025
Asset turnover
0.98×
This company
1.12×
Market median
+13% vs market
2021
2025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on Tatlisumak Medical Consulting Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
